Febuxostat 80 mg prescription tablets recalled for manufacturing contamination
Sun Pharmaceutical is recalling Febuxostat 80 mg tablets due to microbial contamination in manufacturing equipment. Approximately 19,992 bottles were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with manufacturing contamination representing a reasonable probability of adverse health consequences. No illnesses or injuries have been reported, meeting the criterion of risk-of-harm products where injury has not yet been reported.
Plain-English summary
Sun Pharmaceutical Industries, Inc. is recalling Febuxostat 80 mg tablets due to Good Manufacturing Practice deviations. Microbial contamination was identified in stagnant water located in a duct of the manufacturing equipment.
Approximately 19,992 bottles were distributed nationwide. The affected lots are DNE0867A (expiration date 06/30/2025) and DNE0894B (expiration date 07/31/2025). Tablets are identified by NDC 47335-722-83.
Consumers taking Febuxostat from the recalled lots are advised to contact their healthcare provider or pharmacist regarding this recall and available treatment alternatives. Do not discontinue medication without medical guidance. Return recalled bottles to the dispensing pharmacy.
The recalled product
- Product
- FEBUXOSTAT (FEBUXOSTAT)
- Brand
- FEBUXOSTAT
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #s: DNE0867A Exp. 06/30/2025
- DNE0894B Exp. 07/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FEBUXOSTAT
- HighPrescription drug Febuxostat recalled due to manufacturing contamination
FDA (Drugs) · 2024-03-20
- ModerateFebuxostat tablets recalled due to microbial contamination in manufacturing
FDA (Drugs) · 2024-03-20
- ModeratePrescription Drug Febuxostat Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2024-02-14
- ModerateFebuxostat Prescription Tablets Recalled Nationwide for Manufacturing Contamination
FDA (Drugs) · 2024-01-31
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27